Urinary Tract Infection in Symptomatic Benign Prostate Enlargement: Prevalence, Bacteria profile and Antibiotic susceptibility
Keywords:
Bacterial Profile, Prevalance, Urinary Tract InfectionAbstract
The clinical morbidity of urinary tract infection on a background of surgical disease is enormous. This may include urosepsis, renal scarring and renal failure. This does not exclude the financial burden that may be incurred in the management of these cases. Therefore, determining the epidemiological pattern of this clinical condition is invaluable to medical practices in our environment. Our objective was to investigate the prevalence, bacterial profile and antibiotic susceptibility pattern of urinary tract infection in symptomatic benign prostate enlargement This was a hospital based retrospective observational study that was conducted over a period of one year. The case notes of patients that were managed for benign prostate enlargement between July 2024 and June 2025 were retrieved from medical record department of our institution. The information extracted from the case note includes age of the patients, urine microscopy, culture and sensitivity including method of urine sample collection at presentation, history of antibiotic intake and urethral catheterization prior presentation, previous history of urinary tract infection and previous history of urethral instrumentation. Patients with benign prostate enlargement with complete urine m/c/s results were recruited into the study while patients with previous history of UTI, history of antibiotic intake and on an indwelling urethral catheter at presentation were excluded from the study. Prevalence, bacterial profile and antibiotic susceptibility were determined. Out of the number of patients that were managed for symptomatic benign prostate enlargement over the period of review, a total of 46 patients fulfilled the recruitment criteria and they were recruited into the study. The age distribution of the study group showed a range of 43-88 years with mean of 62.5+/ 129sd. The period prevalence of urinary sepsis in this study was 47.8%. Six species of micro-organism were cultured and the most common was Escherichia coli (8, 36.3). Culture sensitivity pattern was done against some antibiotics. The most common sensitive antibiotics were imipenem (9, 40.9%), amikacin (8, 36.3%) Ciprofloxacin (6, 27.2%) and Nitrofurantoin (7, 31.8%)The prevalence of urinary tract infection in BPH patients in our environment was 47.8% and the most commonly involved bacteria was Escherichia coli with imipenem being the most commonly sensitive antibiotic.
References
1. Dobbs RW, Hugar LA, Revenig LM, Al-Qassab U, Petros JA, Ritenour CW, et al. Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer. International braz j urol. 2014;40(2):198-203.
2. Chang S-J, Tsai L-P, Hsu C-K, Yang SS. Elevated postvoid residual urine volume predicting recurrence of urinary tract infections in toilet-trained children. Pediatric nephrology. 2015;30(7):1131-7.
3. Johansen TEB, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, et al. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. International journal of antimicrobial agents. 2011;38:64-70.
4. Antinori S, Pezzani MD. Uncomplicated and complicated urinary tract infections in adults: The infectious diseases’s specialist perspective. Imaging and intervention in urinary tract infections and urosepsis: Springer; 2017. p. 17-33.
5. Bonkat G, Bartoletti R, Bruyere F, Cai T, Geerlings S, Köves B, et al. EAU guidelines on urological infections. European Association of Urology. 2017;18:22-6.
6. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Deutsches Ärzteblatt International. 2010;107(21):361.
7. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clinical infectious diseases. 2004;38(8):1150-8.
8. Bleidorn J, Hummers-Pradier E, Schmiemann G, Wiese B, Gágyor I. Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial. GMS German Medical Science. 2016;14:Doc01.
9. Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiology spectrum. 2016;4(5):10.1128/microbiolspec. uti-0002-2012.
10. Oshodi AJ, Nwabuisi C, Popoola AA, Edungbola LD, Agbede OO, Akanbi II AA, et al. Bacterial uropathogen among benign prostatic hyperplasia patients at a tertiary hospital in Nigeria. Open Journal of Medical Microbiology. 2015;5(01):22.
11. Niccodem EM, Majigo M, Nyongole OV, Manyahi J, Shangali A, Mwingwa AG, et al. Urinary tract infections and associated factors among patients with an enlarged prostate at a tertiary hospital, Dar es Salaam, Tanzania: a hospital-based cross-sectional study. BMJ open. 2024;14(10):e085580.
12. Yue L, Wang T, Ge Y, Ge M, Zhang C, Hou Q, et al. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas. The Prostate. 2019;79(3):312-9.
13. Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and future prospects. Pathogens. 2023;12(4):623.
14. Bono MJ, Reygaert WC. Urinary tract infection. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing. 2022.
15. Moges A, Genetu A, Mengistu G. Antibiotic sensitivities of common bacterial pathogens in urinary tract infections at Gondar Hospital, Ethiopia. East African Medical Journal. 2002;79(3):140-2.
